ADE	antibody mediated disease enhancement
APC	antigen-presenting cell
BAL	bronchoalveolar lavage
CGM	complete growth medium
cGMP	current good manufacturing practice
CpG	cytosine triphosphate deoxynucleotide-guanine triphosphate deoxynucleotide oligodeoxynucleotide
CTL	cytotoxic T lymphocyte
DICOM	digital imaging and communications in medicine
DMSO	dimethyl sulfoxide
EDTA	ethylenediaminetetraacetic acid
ELISPOT	enzyme-linked immune absorbent spot assay
HLA	human leucocyte antigen
IFNγ	interferon gamma
IT	intratracheal
LLOD	lower limit of detection
LN	lymph node
MHC	major histocompatibility complex
MPLA	monophosphoryl lipid A
NHP	non-human primate
PBMC	peripheral blood mononuclear cells
PLGA	poly-L-lactide-co-glycolide
qRT-PCR	real-time quantitative reverse transcription polymerase chain reaction
SARS-CoV-2	severe acute respiratory syndrome coronavirus 2
TCID50	fifty-percent tissue culture infective dose
Th1	T helper cell type 1
Th2	T helper cell type 2
TLR	toll-like receptor
VAERD	vaccine-associated enhanced respiratory disease